Pharmacogenetics of Cannabinoid Response
Conditions
COMT Gene Polymorphism
What is the purpose of this trial?
This study attempts to examine genetic influences on the effects of tetrahydrocannabinol (Δ9-THC), the active ingredient of marijuana, cannabis, "ganja", or "pot".
Participation Guidelines
- Age:
- 18 Years - 55 Years
- Gender:
- Both
Click here for detailed information about who can participate in this trial.
- Sponsor:
- National Institute on Drug Abuse (NIDA)
Yale University - Dates:
- July 2007
- Last Updated:
- October 25, 2012
- Study HIC#:
- 0706002754
Clinicaltrials.gov ID: NCT00678730
For more information about this trial, contact:
Ashley Schnakenberg
203-932-5711 ext 4485
ashley.schnakenberg@yale.edu
Investigator
Deepak D'Souza, MBBS, MD
Principal Investigator
